$SPRO 3 SEC Filings

Filed On	Filing
06 Aug 2026	Form 3: Zack Debra, Chief Medical Officer No securities owned
15 Nov 2023	Form 3: Rajavelu Esther, See Remarks No securities owned
24 Jul 2023	Form 3: DiPalma Stephen J., See Remarks No securities owned
14 Nov 2022	Form 3: Gsk Plc, 10% owner Holds 9,190,606 shares of Common Stock
14 Sep 2022	Form 3: Hamed Kamal, Chief Medical Officer No securities owned
14 Oct 2021	Form 3: Tregoning Kathleen, Director No securities owned
05 Jan 2021	Form 3: Shukla Sath, Chief Financial Officer No securities owned
02 Dec 2020	Form 3: Joseph Tamara L, Chief Legal Officer No securities owned
22 Sep 2020	Form 3: Aquilo Capital Management, Llc, 10% owner and 1 other Holds 4,497,142 shares of Common Stock, $0.001 Par Value
23 Apr 2020	Form 3: Jackson Scott Thomas, Director No securities owned
13 Jan 2020	Form 3: Keutzer Timothy, Chief Development Officer Holds 2,500 shares of Common Stock
08 Nov 2019	Form 3: DiPalma Stephen J., Interim CFO No securities owned
19 Mar 2019	Form 3: Smith Cynthia, Director No securities owned
21 Sep 2018	Form 3: Pottage John C Jr, Director No securities owned
06 Feb 2018	Form 3: Southwell David P, Director No securities owned
05 Jan 2018	Form 3: Melnick David A., Chief Medical Officer No securities owned
02 Nov 2017	Form 3: Glaxosmithkline Plc, 10% owner
01 Nov 2017	Form 3: Halse Reza, Director
01 Nov 2017	Form 3: Sendek Joel, Chief Financial Officer
01 Nov 2017	Form 3: Breum Casper, Director

Comments